Paper2201190
Induction of labor with mifepristone (RU 486) in intrauterine fetal death.
Cabrol D and 9 others. Am J Obstet Gynecol, 1990. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Papers, record 2201190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2201190
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Multicenter Study
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fetal Death | Major topic |
| Labor, Induced | Major topic |
| Mifepristone | Major topic |
| Oxytocics | Major topic |
| Adult | |
| Double-Blind Method | |
| Drug Tolerance | |
| Female | |
| Humans | |
| Multicenter Studies as Topic | |
| Pregnancy | |
| Time Factors |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02488642 | Medical Management of Late Intrauterine Death. | Results |
Source ClinicalTrials.gov
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42350451 | Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers. | NPJ Breast Cancer | 2026 | https://conductscience.org/library/papers/42350451 | PubMed |
| 40221656 | Inducing labor after fetal demise: a systematic review and meta-analysis of the efficacy and safety of mifepristone and misoprostol combination versus misoprostol alone. | BMC Pregnancy Childbirth | 2025 | https://conductscience.org/library/papers/40221656 | PubMed |
| 36158399 | Clinical Utility of Mifepristone: Apprising the Expanding Horizons. | Cureus | 2022 | https://conductscience.org/library/papers/36158399 | PubMed |
| 35928056 | Second-Trimester Medical Abortion with Misoprostol Preceded by Two Sequential Doses of Mifepristone: An Observational Study. | J Obstet Gynaecol India | 2022 | https://conductscience.org/library/papers/35928056 | PubMed |
| 34061352 | Methods for managing miscarriage: a network meta-analysis. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34061352 | PubMed |
| 31206170 | Medical treatment for early fetal death (less than 24 weeks). | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/31206170 | PubMed |
| 28333794 | Route of Delivery in Women With Stillbirth: Results From the Stillbirth Collaborative Research Network. | Obstet Gynecol | 2017 | https://conductscience.org/library/papers/28333794 | PubMed |
| 28138973 | Medical treatments for incomplete miscarriage. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28138973 | PubMed |
| 20091626 | Medical treatments for incomplete miscarriage (less than 24 weeks). | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20091626 | PubMed |
| 19588336 | Mifepristone for induction of labour. | Cochrane Database Syst Rev | 2009 | https://conductscience.org/library/papers/19588336 | PubMed |
| 16855990 | Medical treatment for early fetal death (less than 24 weeks). | Cochrane Database Syst Rev | 2006 | https://conductscience.org/library/papers/16855990 | PubMed |
| 12215721 | Proven and potential clinical applications of mifpristone (RU486). | Rev Endocr Metab Disord | 2002 | https://conductscience.org/library/papers/12215721 | PubMed |
| 9250420 | Clinical pharmacokinetics of mifepristone. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9250420 | PubMed |
| 7682909 | Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. | Drugs | 1993 | https://conductscience.org/library/papers/7682909 | PubMed |
| 1739787 | Medical abortion. | BMJ | 1992 | https://conductscience.org/library/papers/1739787 | PubMed |
| 1281069 | Mifepristone. Separating fact from fiction. | Drugs | 1992 | https://conductscience.org/library/papers/1281069 | PubMed |
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| OXYTOCIN | CHEMBL395429 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL395429 | ChEMBL |
| MISOPROSTOL | CHEMBL606 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL606 | ChEMBL |
| ISOSORBIDE DINITRATE | CHEMBL6622 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL6622 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2201190
GET https://conductscience.org/api/papers/v1/2201190/authors